A systematic review published in JAMA Psychiatry looks at weight loss drugs (GLP-1 receptor agonists) and mental health. Prof Stella Chan, Charlie Waller Chair in Evidence-based Psychological ...

“To delay this progress in order to align with slower EU processes would undermine our ability to deliver resilient, sustainable crops at a time when food security and climate resilience are more ...

Opportunities to deliver the best care possible are being missed. This is a real concern for the Royal College of Psychiatrists and their report makes practical recommendations for clinicians, ...

“We have actually known that nanoparticles can enter the body through the lungs for over 20 years [1]. Many types of nanoparticles, including carbon, gold, silver, zinc oxide, titanium dioxide, and ...

May 12, 2025 expert reaction to Government White Paper on immigration . Scientists comment on R&D elements of the Government’s White Paper on immigration. Sir Adrian Smith, Pres ...

Paper: ‘Glucagon-like peptide-1 receptor agonists compared with bariatric metabolic surgery and the risk of obesity-related cancer: an observational, retrospective cohort study’ by Yael Wolff Sagy et ...

A conference poster presented at the European Congress on Obesity (ECO) looks at weight loss drugs (GLP-1s) and reduced alcohol intake. Prof Kevin McConway, Emeritus Professor of Applied Statistics, ...

A conference press release presented at the European Congress on Obesity (ECO) in Malaga looks at time-restricted eating (TRE) and weight loss in obese adults. Dr Adam Collins, Associate Professor of ...

A study published in JAMA Network Open looks at proximity to Golf Courses and the risk of Parkinson’s Disease.

“There are a number of hormones, mainly anabolic steroids that are classified as growth promoters. They were banned in the EU back in the 1980’s on the grounds they were a food safety risk. This has ...